Oclacitinib, is mainly used in dogs to control pruritus (itching) associated with allergic dermatitis and atopic dermatitis, according to the European Medicines Agency. It works by inhibiting specific enzymes involved in the itch and inflammation pathways, providing relief from these uncomfortable symptoms. It is grouped under the following drug class(es): JAK inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Oclacitinib impurity 13, JAKI and Apoquel. Its PubChem CID is 44631938.
Oclacitinib
| CAS No | 1208319-26-9 |
|---|---|
| Molecular Formula | C15H23N5O2S |
| Molecular Weight | 337.4 g/mol |
| Synonyms | N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oclacitinib, is mainly used in dogs to control pruritus (itching) associated with allergic dermatitis and atopic dermatitis, according to the European Medicines Agency.
The listed CAS number is 1208319-26-9.
The listed molecular formula is C15H23N5O2S.
The listed molecular weight is 337.4 g/mol.
N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide.
The source lists Oclacitinib impurity 13, JAKI and Apoquel.